Cubist Systematic Strategies, LLC Viracta Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.32 - $5.69 $29,395 - $50,379
8,854 Added 65.5%
22,371 $96,000
Q2 2022

Aug 15, 2022
BUY
$1.87 - $5.0 $25,276 - $67,585
13,517 New
13,517 $52,000
Q1 2022

May 16, 2022
SELL
$2.23 - $4.76 $26,670 - $56,929
-11,960 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$3.37 - $7.91 $40,305 - $94,603
11,960 New
11,960 $44,000

Others Institutions Holding VIRX

# of Institutions
41
Shares Held
5.63M
Call Options Held
0
Put Options Held
0
View Full List

About Viracta Therapeutics, Inc.

VIRX Quotes by TradingView
  • Ticker VIRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,558,200
  • Market Cap $9.39M
  • Description
  • Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...
More about VIRX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email